New PreClinical Data for its IL-15 Agonist, NKTR-255 #ASH19 #ASH

Loui Madakamutil, PhD of Nektar Therapeutics discusses new preclinical Ddta for its IL-15 agonist, NKTR-255 at ASH 2019.

___________

Read here: https://www.oncologytube.com/video/nektar-therapeutics-announces-presentation-of-new-preclinical-data-for-its-il-15-agonist-nktr-255-at-the-american-society-of-hematology-ash-2019-annual-meeting